Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report

Javad Nazarian; Gary E. Mason; Cheng Ying Ho; Eshini Panditharatna; Madhuri Kambhampati; L. Gilbert Vezina; Roger J. Packer; Eugene I. Hwang

doi:10.18632/oncotarget.28286

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Addendum:

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report

PDF | How to cite

Oncotarget. 2023; 14:449-449. https://doi.org/10.18632/oncotarget.28286

Metrics: PDF 694 views | ?

Javad Nazarian^1,2, Gary E. Mason³, Cheng Ying Ho⁴, Eshini Panditharatna^1,6, Madhuri Kambhampati¹, L. Gilbert Vezina⁵, Roger J. Packer⁷ and Eugene I. Hwang⁸

¹Center for Genetic Medicine Research, Children’s National Medical Center, Washington, DC, USA
²Department of Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA
³University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
⁴Department of Pathology, Children’s National Medical Center, Washington, DC, USA
⁵Division of Neuro-radiology, Children’s National Medical Center, Washington, DC, USA
⁶Institute for Biomedical Sciences, George Washington University School of Medicine and Health Sciences, Washington, DC, USA
⁷Brain Tumor Institute, Daniel and Jennifer Gilbert Neurofibromatosis Institute, Neuroscience and Behavioral Medicine, Children’s National Medical Center, NW, Washington, DC, USA
⁸Center for Cancer and Blood Disorders, Children’s National Medical Center, Washington, DC, USA

Published: May 12, 2023

Copyright: © 2023 Nazarian et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: Because this was an autopsy-based analysis, autopsy/donation consent was obtained.

Original article: Oncotarget. 2016; 7:42837-42842. DOI: https://doi.org/10.18632/oncotarget.10034.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28286

Publication Alerts

Post-Publication Promotion

Publication Discount

Addendum:

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report